Aethlon Medical establishes ESI seeing that a wholly owned subsidiary Aethlon Medical.

Aethlon Medical establishes ESI seeing that a wholly owned subsidiary Aethlon Medical, Inc. announced today that it has established Exosome Sciences, Inc. as a wholly possessed subsidiary of the business. Aethlon Medical, Inc. Will contribute into ESI all exosome-related patents and patents pending. Jim Joyce, Chief and Chairman Executive Officer of Aethlon Medical, Inc. Said, The capability to reduce circulating exosomes would likely reverse immune suppression and increase patient responsiveness to both immunotherapy and chemotherapy, therefore positioning ESI to take part in the $43 billion malignancy therapy market. ESI plans to progress exosome diagnostic and analysis services also, and explore discovered possibilities to handle exosomes in disease conditions beyond cancer recently.Those eating almonds had a 62 % higher reduction in body mass index rating, 50 % greater reduction in waist circumference, and 56 % greater decrease in body fat in comparison to those on the reduced calorie complex carbohydrate diet. Among those with diabetes, medication reductions were sustained or further low in 96 percent of these on the almond added diet. A study reported within an WHFood’s article on almonds, involving 8865 adults found that those who ate nuts at least 2 times per week were 31 percent less likely to gain weight than were those who never or rarely at them.